Cargando…

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions

OBJECTIVES: Molecular profiling of tumours has become the mainstay of diagnostics for metastasised solid malignancies and guides personalised treatment, especially in nonsmall cell lung cancer (NSCLC). In current practice, it is often challenging to obtain sufficient tumour material for reliable mol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hummelink, Karlijn, Muller, Mirte, Linders, Theodora C., van der Noort, Vincent, Nederlof, Petra M., Baas, Paul, Burgers, Sjaak, Smit, Egbert F., Meijer, Gerrit A., van den Heuvel, Michel M., van den Broek, Daan, Monkhorst, Kim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431750/ https://www.ncbi.nlm.nih.gov/pubmed/30918895 http://dx.doi.org/10.1183/23120541.00016-2019

Ejemplares similares

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients
por: Vessies, Daan C. L., et al.
Publicado: (2022)

PD-1(T) TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC
por: Hummelink, Karlijn, et al.
Publicado: (2022)

Modeling strategies to analyse longitudinal biomarker data: An illustration on predicting immunotherapy non-response in non-small cell lung cancer
por: van Delft, Frederik A., et al.
Publicado: (2022)

New targeted treatments for non-small-cell lung cancer – role of nivolumab
por: Zago, Giulia, et al.
Publicado: (2016)

Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC
por: Schuurbiers, Milou, et al.
Publicado: (2022)

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer
por: Schouten, Robert D., et al.
Publicado: (2021)

Urethral catheters: can we reduce use?
por: van den Broek, Pieter J, et al.
Publicado: (2011)

Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy
por: van Delft, Frederik, et al.
Publicado: (2021)

Evaluating the Application of the Mental Model Mapping Tool (M-Tool)
por: van den Broek, Karlijn L., et al.
Publicado: (2021)

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance
por: Koole, Simone N., et al.
Publicado: (2022)

Can Treadmill Perturbations Evoke Stretch Reflexes in the Calf Muscles?
por: Sloot, Lizeth H., et al.
Publicado: (2015)

Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis
por: Joosten, Pieter J M, et al.
Publicado: (2021)

Preanalytical blood sample workup for cell‐free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics
por: van Ginkel, Joost H., et al.
Publicado: (2017)

Nivolumab in pre-treated advanced non-small cell lung cancer: long term follow up data from the Dutch expanded access program and routine clinical care
por: Schouten, Robert D., et al.
Publicado: (2020)

Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis
por: Liu, W M, et al.
Publicado: (2012)

Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling
por: Guo, Zhihua, et al.
Publicado: (2019)

Resection of a bony tumour of the chest wall with direct reconstruction using a sandwich technique: a standard technique for closure of large chest wall defects
por: Hummelink, Karlijn, et al.
Publicado: (2014)

Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment
por: Otten, Leila S., et al.
Publicado: (2023)

Variable and Asymmetric Range of Enslaving: Fingers Can Act Independently over Small Range of Flexion
por: van den Noort, Josien C., et al.
Publicado: (2016)

Next-Generation Sequencing of Cell-Free DNA Extracted From Pleural Effusion Supernatant: Applications and Challenges
por: Patel, Ami, et al.
Publicado: (2021)

Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers
por: Wu, Huita, et al.
Publicado: (2022)

A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma
por: Kao, Steven C, et al.
Publicado: (2016)

Nucleosomes can invade DNA territories occupied by their neighbors
por: Engeholm, Maik, et al.
Publicado: (2009)

Can We Predict Graft Intolerance Syndrome After Kidney Transplant Failure? External Validation of a Previously Developed Model
por: Bunthof, Kim, et al.
Publicado: (2023)

Can parapneumonic effusion be diagnosed only with pleural fluid analysis?
por: Park, Hyung Jun, et al.
Publicado: (2020)

Supernatants from lymphocytes stimulated with Bacillus Calmette-Guerin can modify the antigenicity of tumours and stimulate allogeneic T-cell responses
por: Liu, W M, et al.
Publicado: (2011)

Can supernatant from immortalized adipose tissue MSC replace cell therapy? An in vitro study in chronic wounds model
por: Kraskiewicz, Honorata, et al.
Publicado: (2020)

Can Quality Improvement Methodologies Derived from Manufacturing Industry Improve Care in Cardiac Surgery? A Systematic Review
por: Hoefsmit, Paulien Christine, et al.
Publicado: (2022)

Can words heal? Using affect labeling to reduce the effects of unpleasant cues on symptom reporting
por: Constantinou, Elena, et al.
Publicado: (2014)

SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response
por: Ibáñez-Molero, Sofía, et al.
Publicado: (2022)

Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review
por: Pluimakers, Vincent G., et al.
Publicado: (2021)

Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung Adenocarcinoma
por: Liu, Dan, et al.
Publicado: (2014)

Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer
por: Li, Jianqiang, et al.
Publicado: (2020)

Broadening the scope for three-dimensional printed airway stents
por: van Beelen, Sophia, et al.
Publicado: (2023)

Antagonistic co-contraction can minimize muscular effort in systems with uncertainty
por: Koelewijn, Anne D., et al.
Publicado: (2022)

Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR‐mutant non‐small cell lung cancer
por: Janssen, Julie M., et al.
Publicado: (2022)

The Homeopathic Preparation Nervoheel N can Offer an Alternative to Lorazepam Therapy for Mild Nervous Disorders
por: van den Meerschaut, Lodewijk, et al.
Publicado: (2009)

The Medical Triazole Voriconazole Can Select for Tandem Repeat Variations in Azole-Resistant Aspergillus Fumigatus Harboring TR(34)/L98H Via Asexual Reproduction
por: Zhang, Jianhua, et al.
Publicado: (2020)

A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer
por: Jin, Shidai, et al.
Publicado: (2020)

Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer
por: Tong, Lin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_et15r3calfahbq49e3np5llrve